| Previous Section | Index | Home Page |
East London and City Health Authority
Mr. Spearing: To ask the Secretary of State for Health, pursuant to his oral statement of 2 December concerning future funding of the East London and City health authority, Official Report, column 686, what was the source of the additional funds he referred to; and when his decisions on the amounts and purposes will be (a) determined and (b) published. [9318]
Mr. Malone: From within the overall settlement for hospital and community health services, revenue funds have been set aside for a number of special purposes.
The procedure and timetable for most of the schemes involved were set out in a circular letter to health authorities--EL(96)109--copies of which are available in the Library.
Decisions on applications for special assistance to health authorities undergoing structural or strategic change will be determined and published individually.
Mrs. Roche:
To ask the Secretary of State for Health how many items of legislation relating to his Department have been repealed since January 1994; how many statutory instruments were introduced during the same period; and how many of the latter were (a) deregulatory and (b) fee orders. [9362]
Mr. Horam:
I refer the hon. Member to the reply my right hon. Friend the Chancellor of the Duchy of Lancaster gave her today.
17 Dec 1996 : Column: 559
Mr. Flynn:
To ask the Secretary of State for Health what assessment his Department has made of (i) afflictions for which the steroid Prednisolone is prescribed, (ii) the side-effects which have been recorded and (iii) the alternative treatments there are for such conditions; and if he will make a statement. [9647]
Mr. Malone:
Prednisolone is a corticosteroid licensed for more than 70 specific indications which are serious or life threatening, such as asthma, malignant diseases, and arthritic disorders.
The side effects of Prednisolone are well known and documented in product information for doctors and patients and in the British National Formulary, copies of which are available in the Library.
Other treatments are available for many of the diseases for which Prednisolone is indicated. These are not usually alternatives, but are used to treat symptoms rather than modify the disease process.
Mr. Flynn:
To ask the Secretary of State for Health how many people (a) have been prescribed and (b) have taken the steroid Prednisolone in each of the last five years; and if he will make a statement. [9646]
Mr. Malone:
It is not possible to identify the number of people who were prescribed Prednisolone.
Mr. Flynn:
To ask the Secretary of State for Health what was the total compensation paid by the NHS in medical negligence claims in each of the last five years; and if he will make a statement. [9651]
Mr. Malone:
I refer the hon. Member to the figures that were given to the hon. Member for Darlington (Mr. Milburn), on 6 March 1995, Official Report, columns 41-42, and 17 May 1996, column, 586, and to the hon. Member for Dulwich (Ms Jowell) on 28 November 1996, Official Report, columns 371-72.
Mr. Flynn:
To ask the Secretary of State for Health how many medical negligence claims have been (i) brought and (ii) been successful against NHS physicians in each of the last five years; and if he will make a statement. [9650]
Mr. Malone:
The information requested is not held centrally.
Mr. Kirkwood:
To ask the Secretary of State for Health how many new registrations on the dental register have been made in each year since 1985; and if he will make a statement. [9443]
17 Dec 1996 : Column: 560
Mr. Malone:
The number of new registrations added to the dental register since 1985 is in the table.
| Registered for | Total |
|---|---|
| 1985 | 1,103 |
| 1986 | 1,036 |
| 1987 | 1,083 |
| 1988 | 1,038 |
| 1989 | 1,047 |
| 1990 | 1,206 |
| 1991 | 1,075 |
| 1992 | 1,141 |
| 1993 | 1,254 |
| 1994(26) | 571 |
| 1995 | 1,041 |
Source:
Dental register.
Note:
(26) The drop in the number added to the register in 1994 is due to the effect of the extension in 1990 of the British dental undergraduate course from four years and one term to five years.
Private Health Insurance
Mr. Kirkwood: To ask the Secretary of State for Health what estimate he has made of the number of people with private health insurance cover in each year since 1979; and if he will make a statement. [9447]
Mr. Horam: The Department does not collect this information.
Medicines Control Agency
Mr. Flynn: To ask the Secretary of State for Health if he will list the names of the members of the Medicines Control Agency together with their (a) other employers, (b) other voluntary and paid work undertaken, (c) length of service and (d) areas of expertise; if he will set out the reasons for their appointment in each case; and if he will make a statement. [9653]
Mr. Malone: The Medicines Control Agency, MCA, is an agency of the Department of Health whose staff are employees of the Department of Health on standard civil service terms and conditions.
Decisions regarding the licensing of medicines are made by the licensing authority--United Kingdom Health Ministers. For all new drugs, the licensing authority seeks the advice of the Committee on Safety of Medicines before deciding whether they should be licensed.
Mr. Flynn:
To ask the Secretary of State for Health what is the (a) total and (b) percentage of funding provided for the Medicines Control Agency by the pharmaceutical companies in the current year; and if he will make a statement. [9652]
Mr. Malone:
Apart from interest earned on bank balances and minor receipts for miscellaneous services, the Medicines Control Agency's income receipts for 1996-97 are currently estimated to total about £25 million, all of which will comprise fees from pharmaceutical companies.
17 Dec 1996 : Column: 561
Mr. Flynn:
To ask the Secretary of State for Health how many prescription drugs damages cases (i) have been brought and (ii) were successful against (a) the NHS and (b) pharmaceutical companies in each of the last five years; and if he will make a statement. [9649]
Mr. Malone:
The information requested is not held centrally.
Mr. Flynn:
To ask the Secretary of State for Health if he will estimate (a) how many and (b) the percentage of people who have been admitted to hospital as a direct result of complications after (i) surgery and (ii) medicinal treatment in each of the last five years; and if he will make a statement. [9648]
Mr. Horam:
Information on hospital admissions following surgical and medical care is set out in the table. As to the number of hospital admissions relating to an adverse reaction to a medicament, I refer the hon. Member to the reply I gave him on 14 November, Official Report, columns 334-35.
| ICD code | Description | 1990-91 | 1991-92 | 1992-93 | 1993-94 | 1994-95 |
|---|---|---|---|---|---|---|
| 996 | Complications peculiar to certain specified procedures | 24,152 | 30,667 | 36,108 | 39,976 | 44,168 |
| 997 | Complications affecting specified body systems, not elsewhere classified | 5,432 | 6,663 | 9,082 | 10,408 | 11,810 |
| 998 | Other complications of procedures, not elsewhere classified | 22,687 | 25,860 | 29,629 | 31,797 | 35,629 |
| 999 | Complications of medical care, not elsewhere classified | 641 | 669 | 826 | 887 | 968 |
| Totals | 52,912 | 68,889 | 75,645 | 83,068 | 92,575 | |
| Percentage | 1.2 | 1.4 | 1.5 | 1.5 | 1.6 |
17 Dec 1996 : Column: 562
Multiple Chemical Sensitivity Disorder
Mr. Alfred Morris: To ask the Secretary of State for Health what representations he has had from the charity Miracles in relation to recognition of multiple chemical sensitivity disorder in the United Kingdom and other issues; what response he is making; what action he plans to take; and if he will make a statement. [9425]
Mr. Horam: I shall let the right hon. Member have such information as is available as soon as possible.
| Next Section | Index | Home Page |